ALR : Summary for Alere Inc. Common Stock - Yahoo Finance

U.S. Markets closed

Alere Inc. (ALR)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
36.67-3.19 (-8.00%)
At close: 4:03 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close39.86
Bid36.20 x 500
Ask36.75 x 100
Day's Range35.62 - 39.75
52 Week Range31.47 - 54.13
Avg. Volume717,159
Market Cap3.19B
PE Ratio (TTM)-52.31
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Moody's4 hours ago

    Abbott Laboratories -- Moody's: Abbott's Move to Terminate Alere Adds Uncertainty

    New York, December 07, 2016-- Moody's Investors Service said that a recent announcement by Abbott Laboratories does not change its expectations for the company's future ratings. On December 7th, Abbott ...

  • American City Business Journals5 hours ago

    Abbott sues Waltham's Alere to end $5.8 billion buyout

    Abbott Laboratories on Wednesday fired the latest salvo in its legal battle with Alere over their $5.8 billion buyout agreement, suing the troubled Waltham diagnostics firm in an effort to terminate the deal. Chicago-based Abbott (ABT) filed a complaint in the Delaware Court of Chancery, where large corporations often go to hash out business disputes, asking a judge to terminate its February buyout on the grounds that Alere (ALR) has been severely damaged since then and has stonewalled requests for information. Alere previously sued Abbott in the same Delaware court in August to enforce the deal.

  • American City Business Journals8 hours ago

    Abbott wants out of $5.8 billion Alere deal

    Abbott Laboratories Inc. is washing its hands of an agreement to acquire health care diagnostics company Alere Inc. The pharmaceutical and medical device giant announced Wednesday that it has filed a complaint with the Delaware Court of Chancery seeking termination of the deal, which has been plagued by a series of setbacks throughout the year. In January, Abbott (ABT) announced it intended to buy Alere for $5.8 billion.